COVID-19住院神经外科患者的多中心病例系列结局与手术考量
该多中心回顾性观察研究纳入2020年3月11日至11月2日Mayo Clinic医疗系统内COVID-19阳性的住院神经外科患者,共11例(占0.68%)。所有患者均有合并症,平均住院13.4天,4例接受神经外科/神经血管内干预,随访期间5例死亡(3例死于COVID-19并发症,2例死于转移癌进展)。结论认为COVID-19在住院神经外科人群中罕见,手术仅限紧急情况。
要点
- 住院神经外科患者中COVID-19阳性率低(0.68%),但所有阳性患者均有合并症。
- 有呼吸道症状的患者住院期间均出现并发症,3例30天内死于COVID-19并发症。
- 神经外科手术仅在对紧急情况时才实施。
核心结论
- COVID-19在住院神经外科人群中罕见,所有患者均有多种合并症。
- 有呼吸道症状的患者住院期间均出现并发症,30天内死亡均与COVID-19并发症相关。
- 神经外科手术仅在对紧急情况时才实施。
研究设计与样本
- 多中心回顾性观察研究,纳入2020年3月11日至11月2日Mayo Clinic及Mayo Clinic Health System内COVID-19阳性的住院神经外科患者。
- 共识别11例住院神经外科患者(0.68%)COVID-19阳性。
主要发现
- 11例中男性4例(36.6%),女性7例(63.3%),平均年龄65.7岁(范围35-81岁)。
- 所有患者均有合并症,平均住院时间13.4天(范围4-30天)。
- 7例有中枢神经系统恶性肿瘤(4例转移瘤、1例脑膜瘤、1例胶质母细胞瘤、1例神经鞘瘤)。
- 3例出现脑血管并发症(2例自发性脑实质出血、1例缺血性大血管卒中),1例为不稳定性创伤性脊柱爆裂骨折。
- 4例接受神经外科/神经血管内干预;出院去向为家庭5例、康复机构3例、临终关怀3例;随访期间5例死亡(3例30天内死于COVID-19并发症,2例死于转移癌进展)。
临床怎么用
- 神经外科应仅对紧急情况实施手术干预。
- 对住院神经外科患者应警惕COVID-19合并症及呼吸道并发症风险。
局限性
- 回顾性观察研究,样本量小(11例),来自单一医疗系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Neurosurgical patients are at a higher risk of having a severe course of coronavirus disease 2019 (COVID-19). The objective of this study was to determine morbidity, hospital course, and mortality of neurosurgical patients during the coronavirus disease 2019 (COVID-19) pandemic in a multicenter health care system. METHODS: A retrospective observational study was conducted to identify all hospitalized neurosurgical patients positive for COVID-19 from March 11, 2020 to November 2, 2020 at Mayo Clinic and the Mayo Clinic Health System. RESULTS: Eleven hospitalized neurosurgical patients (0.68%) were positive for COVID-19. Four patients (36.6%) were men and 7 (63.3%) were women. The mean age was 65.7 years (range, 35-81 years). All patients had comorbidities. The mean length of stay was 13.4 days (range, 4-30 days). Seven patients had a central nervous system malignancy (4 metastases, 1 meningioma, 1 glioblastoma, and 1 schwannoma). Three patients presented with cerebrovascular complications, comprising 2 spontaneous intraparenchymal hemorrhages and 1 ischemic large-vessel stroke. One patient presented with an unstable traumatic spinal burst fracture. Four patients underwent neurosurgical/neuroendovascular interventions. Discharge disposition was to home in 5 patients, rehabilitation facility in 3, and hospice in 3. Five patients had died at follow-up, 3 within 30 days from COVID-19 complications and 2 from progression of their metastatic cancer. CONCLUSIONS: COVID-19 is rare among the inpatient neurosurgical population. In all cases, patients had multiple comorbidities. All symptomatic patients from the respiratory standpoint had complications during their hospitalization. Deaths of 3 patients who died within 30 days of hospitalization were all related to COVID-19 complications. Neurosurgical procedures were performed only if deemed emergent.
引用
- Marenco-Hillembrand L, Erben Y, Suarez-Meade P, et al. Outcomes and Surgical Considerations for Neurosurgical Patients Hospitalized with COVID-19-A Multicenter Case Series. World Neurosurg. 2021. PMID: 34237448. doi:10.1016/j.wneu.2021.06.147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。